| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 392,975 | 378,643 | 388,895 | 456,109 | | Cost of Revenue | 355,152 | 344,038 | 353,097 | 409,559 | | | Gross Profit | 37,823 | 34,605 | 35,798 | 46,550 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 23,034 | 22,491 | 22,344 | 25,269 | | Non Recurring |
-
|
-
| 8,021 | 550 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,789 | 12,114 | 5,433 | 20,731 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 664 | 818 | 616 | 1,129 | | Earnings Before Interest And Taxes | 15,453 | 12,932 | 6,049 | 21,860 | | Interest Expense | 2,532 | 2,680 | 2,733 | 2,930 | | Income Before Tax | 12,921 | 10,252 | 3,316 | 18,930 | | Income Tax Expense | (2,130) | 1,042 | (1,712) | 1,892 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 15,051 | 9,210 | 5,028 | 17,038 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,051 | 9,210 | 5,028 | 17,038 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $15,051 | $9,210 | $5,028 | $17,038 |
|
0.03% Nasdaq 0.00%
0.01 (0.03%) 
Income Statement
